Higher physician payments from drug manufacturer Acadia for Nuplazid (pimavanserin) are associated w...
The public now has access to the first round of data reported by the pharmaceutical and medical-devi...
Tomorrow (September 10) is the deadline to review and dispute the accuracy of data reported by the p...
